Senzime Past Earnings Performance

Past criteria checks 0/6

Senzime's earnings have been declining at an average annual rate of -29%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 43.1% per year.

Key information

-29.0%

Earnings growth rate

-16.0%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate43.1%
Return on equity-46.1%
Net Margin-237.8%
Next Earnings Update17 Feb 2025

Recent past performance updates

Recent updates

Will Senzime (STO:SEZI) Spend Its Cash Wisely?

Feb 20
Will Senzime (STO:SEZI) Spend Its Cash Wisely?

We Think Senzime (STO:SEZI) Can Afford To Drive Business Growth

Sep 01
We Think Senzime (STO:SEZI) Can Afford To Drive Business Growth

Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth

May 18
Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth

How Much Of Senzime AB (publ) (STO:SEZI) Do Insiders Own?

Mar 15
How Much Of Senzime AB (publ) (STO:SEZI) Do Insiders Own?

Shareholders of Senzime (STO:SEZI) Must Be Delighted With Their 607% Total Return

Feb 16
Shareholders of Senzime (STO:SEZI) Must Be Delighted With Their 607% Total Return

We're Hopeful That Senzime (STO:SEZI) Will Use Its Cash Wisely

Jan 19
We're Hopeful That Senzime (STO:SEZI) Will Use Its Cash Wisely

Are Insiders Buying Senzime AB (publ) (STO:SEZI) Stock?

Dec 23
Are Insiders Buying Senzime AB (publ) (STO:SEZI) Stock?

What Kind Of Investors Own Most Of Senzime AB (publ) (STO:SEZI)?

Nov 26
What Kind Of Investors Own Most Of Senzime AB (publ) (STO:SEZI)?

Revenue & Expenses Breakdown

How Senzime makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:SEZI Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2455-13112722
30 Jun 2447-13012521
31 Mar 2441-13112721
31 Dec 2336-13412319
30 Sep 2329-13810621
30 Jun 2324-13710622
31 Mar 2319-14310821
31 Dec 2214-1339819
30 Sep 2213-11410317
30 Jun 2211-1048915
31 Mar 2212-867114
31 Dec 2111-826813
30 Sep 2111-745811
30 Jun 2111-665010
31 Mar 218-56398
31 Dec 209-47318
30 Sep 209-412510
30 Jun 209-36239
31 Mar 209-32227
31 Dec 197-33225
30 Sep 197-34290
30 Jun 194-33260
31 Mar 194-30240
31 Dec 183-24201
30 Sep 181-19150
30 Jun 180-16140
31 Mar 180-13130
31 Dec 170-13120
30 Sep 170-13130
30 Jun 171-12130
31 Mar 172-12120
31 Dec 162-9100
30 Sep 161-890
30 Jun 161-880
31 Mar 160-870
31 Dec 150-870
30 Sep 150-760
30 Jun 150-750
31 Mar 150-750
31 Dec 141-650
30 Sep 141-640
30 Jun 141-540
31 Mar 141-540
31 Dec 131-640

Quality Earnings: SEZI is currently unprofitable.

Growing Profit Margin: SEZI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SEZI is unprofitable, and losses have increased over the past 5 years at a rate of 29% per year.

Accelerating Growth: Unable to compare SEZI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SEZI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: SEZI has a negative Return on Equity (-46.12%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies